Patent details

EP2773205 Title: RIFAXIMIN FOR RETREATING DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME

Basic Information

Publication number:
EP2773205
PCT Application Number:
US2012063380
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP128447679
PCT Publication Number:
WO2013067394
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RIFAXIMIN FOR RETREATING DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
French Title of Invention:
RIFAXIMINE POUR LE TRAITEMENT DU SYNDROME DU CÔLON IRRITABLE AVEC DIARRHÉE
German Title of Invention:
RIFAXIMIN ZUR BEHANDLUNG VON DURCHFALL-REIZDARMSYNDROM
SPC Number:

Dates

Filing date:
02/11/2012
Grant date:
22/05/2024
EP Publication Date:
10/09/2014
PCT Publication Date:
10/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/05/2024
EP B1 Publication Date:
22/05/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/11/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/05/2024
 
 

Name:
Salix Pharmaceuticals, Inc.
Address:
8450 Colonnade Center Drive, Colonnade 1, Raleigh, NC 27615, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
24/06/2024
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
FORBES, William
Address:
United States (US)

2

Name:
MERCHANT, Kunal
Address:
United States (US)

3

Name:
BORTEY, Enoch
Address:
United States (US)

4

Name:
GOLDEN, Pam
Address:
United States (US)

Priority

1

Priority Number:
201161554662 P
Priority Date:
02/11/2011
Priority Country:
United States (US)

2

Priority Number:
201161559686 P
Priority Date:
14/11/2011
Priority Country:
United States (US)

3

Priority Number:
201161560133 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

4

Priority Number:
201161560267 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

5

Priority Number:
201161560128 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

6

Priority Number:
201161560273 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

7

Priority Number:
201161560788 P
Priority Date:
16/11/2011
Priority Country:
United States (US)

8

Priority Number:
201161563033 P
Priority Date:
22/11/2011
Priority Country:
United States (US)

9

Priority Number:
201161564270 P
Priority Date:
28/11/2011
Priority Country:
United States (US)

10

Priority Number:
201261600635 P
Priority Date:
18/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 31/545; A61P 1/08; A61P 1/10; A61P 1/14; A61P 7/00; A61P 11/00; A61P 13/02; A61P 29/00; A61P 31/04; A61P 39/02; A61P 43/00; A61P 1/00; A61P 13/12;

Publication

European Patent Bulletin

Issue number:
202421
Publication date:
22/05/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/10/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/06/2024 Power Of Attorney 1
25/06/2024 Outgoing Correspondence 1